Data collected as part of the European Platform for Neurodegenerative Diseases (EPND) project, including a mixed cohort of 350 individuals with AD, PD, DLB and controls recruited from 7 European studies (10 cohorts): Akershus University Hospital (DDI), Deutsches Zentrum für Neurodegenerative Erkrankungen (DANCER, DELCODE, DESCRIBE, MIGAP), Motol University Hospital (CBAS), Stavanger University Hospital (NOR-DLB); University of Geneva (COSCODE/gMAD), University of Luxembourg (Luxembourgish Parkinson study); VU University Medical Center Amsterdam (ADC). The dataset includes measures of CSF and plasma Aß42, Aß40, p-tau181, NfL, and CSF α-Syn (NeuroToolKit) centrally measured for all participants, with associated data on demographics, clinical factors, lifestyle, rating scales, cognition, samples, genetics and imaging.
Data use terms are below.
